Leading AI executives and security experts are lobbying Congress to create safeguards against AI-enabled biological threats. The group warns that LLMs could lower the barrier for creating pathogens. This push for oversight targets specific model capabilities. Practitioners should expect stricter compliance requirements for high-risk biological research and model deployment.